Recruiting

Acetylcysteine

Sponsor:

Eastern Virginia Medical School

Code:

NCT00396396

Conditions

Creatinine Clearance

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Acetylcysteine

Study Details

Brief summary:

The purpose of this study is to investigate the exact role of Acetylcysteine (Mucomyst) in altering creatinine clearance. Prior studies have shown the protective effects of Acetylcysteine on contrast-induced renal dysfunction. In these studies, Acetylcysteine lowered the incidence of serum creatinine elevation after administration of radiographic contrast agents. Not only was the increase in serum creatinine prevented, the studies also demonstrated a significant increase in creatinine clearance after administration of the agent. These prior studies did not evaluate if the increase in creatinine clearance was indeed from a protective benefit of Acetylcysteine in preserving the GFR versus simply increasing the proximal tubular creatinine secretion without actually affecting the GFR. We propose an experiment to help support our hypothesis that Acetylcysteine increases creatinine clearance via an increase in proximal tubular secretion of creatinine.

Conditions

Creatinine Clearance

Study ID

NCT00396396

Start date

Oct, 2006

Status verified date

Nov, 2006

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Between the ages of 18 and 79 years
2. In good general health
3. Able to provide informed consent

Exclusion Criteria:

1. Allergy to acetylcysteine or cimetidine,
2. Age less than 18 years or greater than 79 years of age,
3. Women of childbearing age and not able to use adequate contraception, or 4. Anyone currently on any medication that interferes with tubular secretion of creatinine such as trimethoprim-sulfamethoxazole (Bactrim).

Study Design

Enrollment

35 participants

Allocation

Non randomized

Intervention Model

Crossover

Interventions and Outcome Measures

Interventions

Acetylcysteine

Central Contacts and Locations

Central contacts

Locations

Eastern Virginia Medical School/Nephrology Associates

Recruiting

Norfolk, Virginia, United States, 23507

Principal Investigator:

Thomas R. McCune, MD

More Information

Sponsor

Eastern Virginia Medical School

Last update posted

Nov 6, 2006

Last verified

Nov, 2006

Keywords

  • Creatinine clearance
  • Acetylcysteine

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Eastern Virginia Medical School on 2006-11-06.